Skip to content

Clinical trials

Carcinoma, Lobular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Lobular Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20043
20056
20073
20084
20094
20104
20112
20121
20132
20142
20161
20183
20192
20201
20212
20222
20236
20245
20251
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting13
Active, not recruiting9
Unknown status7
Terminated5
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center4
City of Hope Medical Center3
Dana-Farber Cancer Institute3
Intarcia Therapeutics3
Abramson Cancer Center at Penn Medicine2
Alliance for Clinical Trials in Oncology2
Auxilio Mutuo Cancer Center2
Blue Earth Diagnostics2
European Institute of Oncology2
Rutgers, The State University of New Jersey2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Lobular67
Breast Neoplasms40
Carcinoma, Ductal, Breast27
Carcinoma, Intraductal, Noninfiltrating17
Breast Carcinoma In Situ14
Inflammatory Breast Neoplasms6
Breast Neoplasms, Male5
Lung Neoplasms3
Neoplasm Metastasis3
Neoplasms, Hormone-Dependent3

Trials

Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.